These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 30396281)

  • 1. Infant Temperament in the
    Tonnsen BL; Wheeler AC; Hamrick LR; Roberts JE
    J Clin Child Adolesc Psychol; 2019; 48(3):412-422. PubMed ID: 30396281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuropsychiatry of fragile X-premutation carriers with and without fragile X-associated tremor-ataxia syndrome: implications for neuropsychology.
    Bourgeois JA
    Clin Neuropsychol; 2016 Aug; 30(6):913-28. PubMed ID: 27355575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incomplete silencing of full mutation alleles in males with fragile X syndrome is associated with autistic features.
    Baker EK; Arpone M; Aliaga SM; Bretherton L; Kraan CM; Bui M; Slater HR; Ling L; Francis D; Hunter MF; Elliott J; Rogers C; Field M; Cohen J; Cornish K; Santa Maria L; Faundes V; Curotto B; Morales P; Trigo C; Salas I; Alliende AM; Amor DJ; Godler DE
    Mol Autism; 2019; 10():21. PubMed ID: 31073396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FMR1 gene mutations in patients with fragile X syndrome and obligate carriers: 30 years of experience in Chile.
    Santa María L; Aliaga S; Faundes V; Morales P; Pugin Á; Curotto B; Soto P; Peña MI; Salas I; Alliende MA
    Genet Res (Camb); 2016 Jun; 98():e11. PubMed ID: 27350105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The FMR1 promoter is selectively hydroxymethylated in primary neurons of fragile X syndrome patients.
    Esanov R; Andrade NS; Bennison S; Wahlestedt C; Zeier Z
    Hum Mol Genet; 2016 Nov; 25(22):4870-4880. PubMed ID: 28173181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [FMR1 PREMUTATION CARRIERS - ARE THEY REALLY ASYMPTOMATIC?].
    Elizur S; Berkenstadt M; Ries-Levavi L; Gruber N; Pinhas-Hamiel O; Hassin-Baer S; Raas-Rothschild A; Raanani H; Cukierman-Yaffe T; Orvieto R; Cohen Y; Gabis L
    Harefuah; 2018 Apr; 157(4):241-244. PubMed ID: 29688643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Granulosa cell and oocyte mitochondrial abnormalities in a mouse model of fragile X primary ovarian insufficiency.
    Conca Dioguardi C; Uslu B; Haynes M; Kurus M; Gul M; Miao DQ; De Santis L; Ferrari M; Bellone S; Santin A; Giulivi C; Hoffman G; Usdin K; Johnson J
    Mol Hum Reprod; 2016 Jun; 22(6):384-96. PubMed ID: 26965313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preliminary evidence of an effect of cerebellar volume on postural sway in FMR1 premutation males.
    Birch RC; Hocking DR; Cornish KM; Menant JC; Georgiou-Karistianis N; Godler DE; Wen W; Hackett A; Rogers C; Trollor JN
    Genes Brain Behav; 2015 Mar; 14(3):251-9. PubMed ID: 25689687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The behavioral phenotype of FMR1 mutations.
    Boyle L; Kaufmann WE
    Am J Med Genet C Semin Med Genet; 2010 Nov; 154C(4):469-76. PubMed ID: 20981777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fragile X syndrome and fragile X-associated tremor ataxia syndrome.
    Hall DA; Berry-Kravis E
    Handb Clin Neurol; 2018; 147():377-391. PubMed ID: 29325626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Fragile X premutation: new insights and clinical consequences.
    Van Esch H
    Eur J Med Genet; 2006; 49(1):1-8. PubMed ID: 16473304
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Fyke W; Velinov M
    Genes (Basel); 2021 Aug; 12(8):. PubMed ID: 34440392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CGG-repeat dynamics and
    Zhou Y; Kumari D; Sciascia N; Usdin K
    Mol Autism; 2016; 7():42. PubMed ID: 27713816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetics of fragile X syndrome and fragile X-related disorders.
    Kraan CM; Godler DE; Amor DJ
    Dev Med Child Neurol; 2019 Feb; 61(2):121-127. PubMed ID: 30084485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fragile X syndrome: a review of clinical and molecular diagnoses.
    Ciaccio C; Fontana L; Milani D; Tabano S; Miozzo M; Esposito S
    Ital J Pediatr; 2017 Apr; 43(1):39. PubMed ID: 28420439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implications of the
    Wheeler A; Raspa M; Hagerman R; Mailick M; Riley C
    Pediatrics; 2017 Jun; 139(Suppl 3):S172-S182. PubMed ID: 28814538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Validation of Fragile X Syndrome Screening by DNA Methylation Array.
    Schenkel LC; Schwartz C; Skinner C; Rodenhiser DI; Ainsworth PJ; Pare G; Sadikovic B
    J Mol Diagn; 2016 Nov; 18(6):834-841. PubMed ID: 27585064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Point mutation frequency in the FMR1 gene as revealed by fragile X syndrome screening.
    Handt M; Epplen A; Hoffjan S; Mese K; Epplen JT; Dekomien G
    Mol Cell Probes; 2014; 28(5-6):279-83. PubMed ID: 25171808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Temperament factor structure in fragile X syndrome: the children's behavior questionnaire.
    Roberts JE; Tonnsen BL; Robinson M; McQuillin SD; Hatton DD
    Res Dev Disabil; 2014 Feb; 35(2):563-71. PubMed ID: 24380785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Health problems in females carriers of premutation in the FMR1 gene.
    Lisik MZ
    Psychiatr Pol; 2017 Oct; 51(5):899-907. PubMed ID: 29289969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.